What's New: Drugs RSS Feed

  • Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020

    Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020

    Coronavirus (COVID-19) Update: Daily Roundup

    Learn More
  • Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic

    Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic

    During the unprecedented COVID-19 pandemic, the FDA recognizes that there has been public interest around expediting the development and availability of a number of potential treatment options.

    Learn More
  • Drugs

    Drugs

    Consumer articles about over-the-counter and prescription drugs.

    Learn More
  • Consumer Updates

    Consumer Updates

    Get timely, reliable, health and safety information about food, drugs, medical devices, vaccines, pet food, pet medicine and more.

    Learn More
  • FDA Voices on Policy

    FDA Voices on Policy

    FDA Voices on Policy

    Learn More
  • FDA Voices

    FDA Voices

    Insights into the agency's work in the areas of medical products, food, tobacco, policy, consumer safety and enforcement.

    Learn More
  • Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19

    Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19

    There are no FDA-approved coronavirus preventions or treatments. Researchers are studying new drugs, and drugs approved for other conditions, as possible preventions or treatments for COVID-19....

    Learn More
  • Search List of Extended Use Dates to Assist with Drug Shortages

    Search List of Extended Use Dates to Assist with Drug Shortages

    This is to update and consolidate the extended use date information posted previously to assist with drug shortage (6/15/17 to present).

    Learn More
  • Over-The-Counter Monograph User Fee Program (OMUFA)

    Over-The-Counter Monograph User Fee Program (OMUFA)

    A user fee program for nonprescription (over-the-counter or OTC) monograph drugs would be a potential funding mechanism to supplement congressional non user-fee appropriations.

    Learn More
  • What's New Related to Drugs

    What's New Related to Drugs

    Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

    Learn More
  • Warning Letters 2020

    Warning Letters 2020

    Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the recipient of the letter that may have changed the regulatory status of the issues...

    Learn More
  • COVID MyStudies Application (App)

    COVID MyStudies Application (App)

    FDA is making its MyStudies app available to investigators as a free platform to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not...

    Learn More
  • FDA’s MyStudies Application (App) Technical Background

    FDA’s MyStudies Application (App) Technical Background

    FDA is making its MyStudies app available to investigators as a free platform to obtain informed consent securely and remotely.

    Learn More
  • Pescatlantic Group, LLC - 496990 - 05/26/2020

    Pescatlantic Group, LLC - 496990 - 05/26/2020

    Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions

    Learn More
  • Development Considerations of Antifungal Drugs to Address Unmet Medical Need - 08/04/2020 - 08/04/2020

    Development Considerations of Antifungal Drugs to Address Unmet Medical Need - 08/04/2020 - 08/04/2020

    Clinical Trial Design Considerations for the Development of Antifungal Drugs

    Learn More
  • Shoreside Enterprises Inc. - 422722 - 05/26/2020

    Shoreside Enterprises Inc. - 422722 - 05/26/2020

    Unapproved New Drugs/Misbranded

    Learn More
  • FDA In Brief: FDA Takes Actions to Enhance Utility of the Orange Book

    FDA In Brief: FDA Takes Actions to Enhance Utility of the Orange Book

    Today, the FDA published the draft guidance “Orange Book: Questions and Answers” to help stakeholders and the public effectively use the Orange Book, as well as two Federal Register notices to...

    Learn More
  • Anesthetic and Analgesic Drug Products Advisory Committee Charter

    Anesthetic and Analgesic Drug Products Advisory Committee Charter

    This is the Charter for the Anesthetic and Analgesic Drug Products Advisory Committee.

    Learn More
  • StayWell Copper Products - 607773 - 05/28/2020

    StayWell Copper Products - 607773 - 05/28/2020

    Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • Quadrant Sales & Marketing, Inc. - 607625 - 05/28/2020

    Quadrant Sales & Marketing, Inc. - 607625 - 05/28/2020

    Unapproved New Drug Products Related to Coronavirus Disease 2019 (COVID-19)

    Learn More
  • loading
    Loading More...